| 1 |
33742767 | Exploratory window-of-opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer. | 2022 Jan |
2 |
| 2 |
30716099 | The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate. | 2019 |
1 |
| 3 |
28036295 | Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells. | 2017 Feb 7 |
1 |
| 4 |
27387230 | The small-molecule IAP antagonist AT406 inhibits pancreatic cancer cells in vitro and in vivo. | 2016 Sep 9 |
1 |
| 5 |
26485762 | SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells. | 2015 Nov 10 |
1 |